SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Approves Merck & Co., Inc.'s Combination Therapy Juvisync; First Combination Drug to Treat type 2 Diabetes and High Cholesterol in one Tablet